JP2022545782A5 - - Google Patents

Info

Publication number
JP2022545782A5
JP2022545782A5 JP2022510801A JP2022510801A JP2022545782A5 JP 2022545782 A5 JP2022545782 A5 JP 2022545782A5 JP 2022510801 A JP2022510801 A JP 2022510801A JP 2022510801 A JP2022510801 A JP 2022510801A JP 2022545782 A5 JP2022545782 A5 JP 2022545782A5
Authority
JP
Japan
Application number
JP2022510801A
Other languages
Japanese (ja)
Other versions
JPWO2021032851A5 (https=
JP2022545782A (ja
Filing date
Publication date
Priority claimed from GBGB1911957.7A external-priority patent/GB201911957D0/en
Application filed filed Critical
Publication of JP2022545782A publication Critical patent/JP2022545782A/ja
Publication of JPWO2021032851A5 publication Critical patent/JPWO2021032851A5/ja
Publication of JP2022545782A5 publication Critical patent/JP2022545782A5/ja
Pending legal-status Critical Current

Links

JP2022510801A 2019-08-20 2020-08-20 多能性幹細胞から造血性前駆細胞を生産する方法 Pending JP2022545782A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1911957.7 2019-08-20
GBGB1911957.7A GB201911957D0 (en) 2019-08-20 2019-08-20 Methods of producing haemogenic progenitor cells from pluripotent stem cells
PCT/EP2020/073396 WO2021032851A1 (en) 2019-08-20 2020-08-20 Methods of producing haemogenic progenitor cells from pluripotent stem cells

Publications (3)

Publication Number Publication Date
JP2022545782A JP2022545782A (ja) 2022-10-31
JPWO2021032851A5 JPWO2021032851A5 (https=) 2023-08-18
JP2022545782A5 true JP2022545782A5 (https=) 2023-08-18

Family

ID=68099409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022510801A Pending JP2022545782A (ja) 2019-08-20 2020-08-20 多能性幹細胞から造血性前駆細胞を生産する方法

Country Status (12)

Country Link
US (1) US20220267733A1 (https=)
EP (1) EP4017967A1 (https=)
JP (1) JP2022545782A (https=)
KR (1) KR20220049032A (https=)
CN (1) CN114269906A (https=)
AU (1) AU2020332863A1 (https=)
BR (1) BR112022003089A2 (https=)
CA (1) CA3150427A1 (https=)
GB (1) GB201911957D0 (https=)
IL (1) IL290605A (https=)
MX (1) MX2022001960A (https=)
WO (1) WO2021032851A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11591381B2 (en) 2020-11-30 2023-02-28 Crispr Therapeutics Ag Gene-edited natural killer cells
WO2022144632A1 (en) 2020-12-30 2022-07-07 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into nk cells
GB202102297D0 (en) * 2021-02-18 2021-04-07 Adaptimmune Ltd Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells
CN113046318B (zh) * 2021-04-13 2023-04-18 中国科学院深圳先进技术研究院 一种诱导多能干细胞向造血前体细胞分化的培养基以及方法
EP4326852A4 (en) * 2021-04-22 2025-04-23 Artec Biotech, Inc. Method for producing hematopoietic cells from stem cells using vascular organoids
CN113265377B (zh) * 2021-06-11 2023-01-24 中国医学科学院血液病医院(中国医学科学院血液学研究所) 一种动脉内皮促进功能性t细胞再生的方法
JP2024531626A (ja) * 2021-09-10 2024-08-29 スンクワン メディカル ファウンデーション 分化全能性幹細胞由来の造血幹細胞の製造方法、及び製造された造血幹細胞を利用したヒト化マウスモデル作製方法
CN116410927A (zh) * 2021-12-31 2023-07-11 士泽生物医药(苏州)有限公司 干细胞诱导分化为造血祖细胞的方法
CN116376822A (zh) * 2021-12-31 2023-07-04 北京大学 利用人多潜能干细胞体外制备t淋巴细胞
TW202340453A (zh) * 2022-01-28 2023-10-16 中國大陸商杭州啟函生物科技有限公司 用於基於細胞的免疫療法的方法和組合物
GB202205572D0 (en) 2022-04-14 2022-06-01 Adaptimmune Ltd Engineered T cells
GB202208545D0 (en) 2022-06-10 2022-07-27 Adaptimmune Ltd Production of immune cells
CN114958771B (zh) * 2022-06-27 2023-12-05 广东康盾创新产业集团股份公司 一种ipsc-car-nk细胞的制备方法
CN115247151B (zh) * 2022-09-21 2022-12-27 呈诺再生医学科技(北京)有限公司 制备造血内皮细胞的方法及制备造血干细胞或造血干祖细胞的方法
KR20240054468A (ko) * 2022-10-18 2024-04-26 의료법인 성광의료재단 줄기세포에서 대식세포로의 분화 유도용 배지 조성물 및 이를 이용한 분화 방법
US20240316196A1 (en) * 2022-12-02 2024-09-26 Nuwacell Biotechnologies Co., Ltd. Methods and compositions for differentiation of pluripotent stem cells and derived natural killer cells
CN117264888A (zh) * 2023-10-11 2023-12-22 苏州艾凯利元生物科技有限公司 一种制备造血干细胞和祖细胞的方法
GB202318950D0 (en) 2023-12-12 2024-01-24 Adaptimmune Ltd Production of immune cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008151390A1 (en) * 2007-06-15 2008-12-18 Australian Stem Cell Centre Ltd Differentiation of human embryonic stem cells
JP5777115B2 (ja) * 2010-03-18 2015-09-09 国立大学法人京都大学 多能性幹細胞から中胚葉細胞への分化誘導法
JP6677631B2 (ja) * 2013-03-13 2020-04-08 ウイスコンシン アラムナイ リサーチ ファウンデーシヨンWisconsin Alumni Research Foundation 定義された条件下におけるヒト多能性幹細胞の造血内皮分化のための方法及び材料
CA2925774A1 (en) * 2013-10-01 2015-04-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human ipsc-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings
AU2016211671B2 (en) * 2015-01-26 2022-05-26 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
CA2975268A1 (en) * 2015-02-20 2016-08-25 Wisconsin Alumni Research Foundation Generating arterial endothelial cell populations
JP6928604B2 (ja) * 2015-11-04 2021-09-01 フェイト セラピューティクス,インコーポレイテッド 万能性細胞のゲノム改変
CA3003152A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
US11261430B2 (en) * 2016-05-03 2022-03-01 The Children's Medical Center Corporation Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells
EP3621630A4 (en) * 2017-06-14 2021-03-10 The Children's Medical Center HEMATOPOIETIC STEM AND PRECURSOR CELLS FROM HEMOGENIC ENDOTHELIAL CELLS BY EPISOMAL PLASMID GENERAL TRANSFER
SG11202006731VA (en) * 2018-01-18 2020-08-28 Agency Science Tech & Res Method for differentiation of human pluripotent stem cell lines in suspension culture
GB202006903D0 (en) * 2020-05-11 2020-06-24 Adaptimmune Ltd Modified iPSCs

Similar Documents

Publication Publication Date Title
JP2022545782A5 (https=)
CN306085710S (https=)
CN306016077S (https=)
CN305536875S (https=)
CN305536611S (https=)
CN305535113S (https=)
CN305534749S (https=)
CN305755467S (https=)
CN305533559S (https=)
CN305531480S (https=)
CN305530508S (https=)
CN305530468S (https=)
CN305529519S (https=)
CN305529293S (https=)
CN305529088S (https=)
CN305528891S (https=)
CN305528315S (https=)
CN305528004S (https=)
CN306077827S (https=)
CN306015715S (https=)
CN306015702S (https=)
CN306015214S (https=)
CN306013162S (https=)
CN306009176S (https=)
CN306007344S (https=)